JOURNAL OF CHEMICAL RESEARCH 2014 497
Isonicotinic acid benzylidenehydrazide (1b): White powder, yield
80%; m.p. 145–147 °C (EtOH); IR (KBr) (νmax, cm–1): 1678 (C=O); 1H
NMR: δ 6.73 (1H, broad s, NH), 7.23–8.67 (9H, m, aromatic), 8.24
(1H, s, N=CH) ppm; 13C NMR: δ 121.9, 127.1, 128.7, 129.4, 133.3, 141.5
and 151.5 (aromatic), 157.5 (C=N), 168.1 (C=O) ppm; MS (m/z,%): 225
(M+, 4). Anal calcd for C13H11N3O: C, 69.32; H, 4.92; N, 18.65; found:
C, 67.52; H, 4.85; N, 18.74%.
157.3 (C=N), 167.5 (C=O) ppm; MS (m/z,%): 267 (M+, 7). Anal calcd
for C15H13N3O2: C, 67.41; H, 4.90; N, 15.72; found: C, 67.55; H, 5.02; N,
15.63%.
1-(5-Furan-2-yl-2-phenyl-[1,3,4]oxadiazol-3-yl)ethanone (3c):
White powder, yield 87%; m.p. 124–126 °C (EtOH);, IR (KBr) (νmax
,
cm–1): 1671 (C=O); H NMR: δ 2.26 (3H, s, NCOCH3), 6.19 (1H, s,
CH), 6.52 (1H, m, CH furan), 7.40 (1H, s, CH furan), 7.63 (1H, d,
3JHH =2 Hz, CH furan), 7.23–8.07 (5H, m, aromatic) ppm; 13C NMR: δ
21.4 (CH3), 90.6 (CH), 111.7, 120.6, 143.5 and 145.6 (4C Furan), 126.9,
128.8, 129.1, 132.9, (aromatic), 157.5 (C=N), 167.7 (C=O) ppm; MS
(m/z,%): 256 (M+, 3). Anal calcd for C14H12N2O3: C, 65.62; H, 4.72; N,
10.93; found: C, 65.78; H, 4.90; N, 10.85%.
1
Furan-2-carboxylic acid benzylidenehydrazide (1c): White powder,
yield 77%; m.p. 112–114 °C (EtOH);, IR (KBr) (νmax, cm–1): 1672
1
(C=O); H NMR: δ 6.47 (1H, m, CH furan), 6.61 (1H, broad s, NH),
3
7.45 (1H, s, CH furan), 7.60 (1H, d, JHH =2 Hz, CH furan), 7.23–8.17
(5H, m, aromatic), 8.34 (1H, s, N=CH) ppm; 13C NMR: δ 111.5, 120.5,
143.7 and 145.5 (4C Furan), 126.7, 128.6, 129.2, 132.8, (aromatic), 157.7
(C=N), 167.5 (C=O) ppm; MS (m/z,%): 214 (M+, 7). Anal calcd for
C12H10N2O2: C, 67.28; H, 4.71; N, 13.08; found: C, 67.40; H, 4.65; N,
13.22%.
1-(2,5-Diphenyl-[1,3,4]oxadiazol-3-yl)ethanone (3d): White powder,
yield 93%; m.p. 111–113 °C (EtOH); IR (KBr) (νmax, cm–1): 1667
(C=O); 1H NMR: δ 2.14 (3H, s, NCOCH3), 6.10 (1H, s, CH), 7.23–8.16
(10H, m, aromatic) ppm; 13C NMR: δ 21.2 (CH3), 90.2 (CH), 126.7,
127.00, 128.7, 128.8, 129.1, 129.1, 132.4 and 132.5 (aromatic), 157.2
(C=N), 167.4 (C=O) ppm; MS (m/z,%): 266 (M+, 5). Anal calcd for
C16H14N2O2: C, 72.17; H, 5.30; N, 10.52; found: C, 72.30; H, 5.41; N,
10.60%.
Benzoic acid benzylidenehydrazide (1d): White powder, yield 82%;
m.p. 125–127 °C (EtOH); IR (KBr) (νmax, cm–1): 1667 (C=O); 1H NMR:
δ 6.55 (1H, broad s, NH), 7.27–8.27 (10H, m, aromatic), 8.30 (1H, s,
N=CH) ppm; 13C NMR: δ 126.6, 127.1, 128.6, 128.9, 129.1, 129.2, 132.4
and 132.6 (aromatic), 157.3 (C=N), 167.5 (C=O) ppm; MS (m/z,%): 225
(M+, 3). Anal calcd for C14H12N2O: C, 74.98; H, 5.39; N, 12.49; found:
C, 75.15; H, 5.50; N, 12.35%.
Benzoic acid (4-chlorobenzylidene)hydrazide (1f): White powder,
yield 85%; m.p. 103–107 °C (EtOH); IR (KBr) (νmax, cm–1): 1672
(C=O); 1H NMR: δ 6.48 (1H, broad s, NH), 7.23–8.22 (5H, m,
aromatic), 7.40 (2H, d, 3JHH =7 Hz, aromatic), 7.75 (2H, d, 3JHH =7 Hz,
aromatic), 8.41 (1H, s, N=CH) ppm; 13C NMR: δ 126.8, 128.7, 128.6,
129.0, 129.3, 132.5, 133.1 and 135.7 (aromatic), 156.5 (C=N), 167.5
(C=O) ppm; MS (m/z,%): 258 (M+, 5). Anal calcd for C14H11ClN2O: C,
65.00; H, 4.29; N, 10.83; found: C, 65.13; H, 4.20; N, 10.90%.
1-[2-(4-Chlorophenyl)-5-methyl-[1,3,4]oxadiazol-3-yl]ethanone
(3e): White powder, yield 94%; m.p. 148–150 °C (EtOH); IR (KBr)
1
(νmax, cm–1): 1675 (C=O); H NMR: δ 2.04 (3H, s, CH3), 2.28 (3H, s,
3
NCOCH3), 6.15 (1H, s, CH), 7.36 (2H, d, JHH =7 Hz, aromatic), 7.65
(2H, d, 3JHH =7 Hz, aromatic) ppm; 13C NMR: δ 11.1 (CH3), 21.4 (CH3),
90.3 (CH), 128.8, 129.1, 133.1 and 135.8 (aromatic), 156.8 (C=N), 167.6
(C=O) ppm; MS (m/z,%): 238 (M+, 6). Anal calcd for C11H11ClN2O2: C,
55.36; H, 4.65; N, 11.74; found: C, 55.28; H, 4.50; N, 11.87%.
1-[2-(4-Chlorophenyl)-5-phenyl-[1,3,4]oxadiazol-3-yl]ethanone
(3f): White powder, yield 92%; m.p. 120–122 °C (EtOH); IR (KBr)
1
(νmax, cm–1): 1670 (C=O); H NMR: δ 2.10 (3H, s, NCOCH3), 6.11
3
(1H, s, CH), 7.23–8.12 (5H, m, aromatic), 7.34 (2H, d, JHH =7 Hz,
General procedure:
3
aromatic), 7.68 (2H, d, JHH =7 Hz, aromatic) ppm; 13C NMR: δ 21.2
Compound 1 (1 mmol) was dissolved in a mixture of pyridine
(2.5 mL) and acetic anhydride (2.5 mL), refluxed for 5 h, and then
left to reach room temperature. Once cold, some ethanol was added
and evaporation at reduced pressure gave a glassy residue which was
subjected to silica gel column chromatography using hexane/ethyl
acetate as the eluent. The product was recrystallised from EtOH.
1-(5-Methyl-2-phenyl-[1,3,4]oxadiazol-3-yl)ethanone (3a): White
powder, yield 89%; m.p. 154–156 °C (EtOH); IR (νmax, cm–1): 1668
(CH3), 90.3 (CH), 126.7, 128.7, 128.8, 129.1, 129.2, 132.4, 133.1 and
135.8 (aromatic), 156.7 (C=N), 167.6 (C=O) ppm; MS (m/z,%): 300 (M+,
7). Anal calcd for C16H13ClN2O2: C, 63.90; H, 4.36; N, 9.31; found: C,
63.72; H, 4.52; N, 9.20%.
Received 30 May 2014 ; accepted 10 July 2014
Paper 1402698 doi : 10.3184/174751914X14057771815483
Published online : 12 August 3014
1
(C=O); H NMR: δ 2.01 (3H, s, CH3), 2.27 (3H, s, NCOCH3), 6.12
(1H, s, CH), 7.23–8.13 (5H, m, aromatic) ppm; 13C NMR: δ 11.1 (CH3),
21.2 (CH3), 90.3 (CH), 126.7, 128.8, 129.1 and 132.5 (aromatic), 156.7
(C=N), 167.4 (C=O) ppm; MS (m/z,%): 204 (M+, 5). Anal calcd for
C11H12N2O2: C, 64.69; H, 5.92; N, 13.72; found: C, 64.50; H, 5.83; N,
13.60%.
References
1
2
S. Rollas and S. Karakus, Marmara Pharm. J., 2012, 16, 120.
V.K.R. Sahu, A.K. Singh and D. Yadav, Int. J. Chem. Tech. Res., 2011, 3,
1362.
1-(2-Phenyl-5-pyridin-4-yl-[1,3,4]oxadiazol-3-yl)ethanone (3b):
3
4
M.A. Martins Alho, R. Baggio and N.B. D’Accorso, Arkivoc, 2013, iii, 129.
White powder, yield 90%), m.p. 132–135 °C (EtOH); IR (KBr) (νmax
,
1
cm–1): 1666 (C=O); H NMR: δ 2.20 (3H, s, NCOCH3), 6.17 (1H, s,
CH), 7.28–8.58 (9H, m, aromatic) ppm; 13C NMR: δ 21.3 (CH3), 90.4
(CH), 122.3, 127.1, 128.8, 129.2, 133.1, 141.7 and 151.6 (aromatic),
5
D. Han, X.‑B. Meng, L.‑N. Wang, H. Liu, Y. Yao, Z. Wang, Z.‑J. Yang,
Z.‑M. Liu and Z.‑J. Li, Tetrahedron-Asymmetr., 2009, 20, 399.